The September incident involved a complex antibiotic regimen prescribed by a nurse practitioner to treat the UTI. The plan called for multiple medications with precise timing: Meropenem 500 mg intravenously daily for seven days starting September 9, followed by Levofloxacin in two different doses and schedules.
But the resident never received critical parts of the treatment.
The medication administration record shows a missed dose of Meropenem 500 mg on September 14 at 9 AM. More significantly, there is no documentation that the resident ever received the ordered Levofloxacin 750 mg dose that was supposed to start on September 13.
A licensed practical nurse documented the problem in a progress note at 3:25 AM on September 14, writing about a call to the pharmacy regarding Levofloxacin that "would be delivered early in AM."
The medication still had not arrived by evening. Another nursing progress note from 6:42 PM that same day states "Levofloxacin 750 MG was not available and would be delivered that night."
The Director of Nursing confirmed to federal inspectors that the resident never received either the missed Meropenem dose or the Levofloxacin 750 mg dose. She stated she received no authorization requests from the pharmacy for the one-time Levofloxacin dose, and there was no documentation showing the resident received it.
The facility's own policy from November 2021 requires licensed nurses to "promptly report discrepancies and omissions to the issuing pharmacy and the charge nurse/supervisor." While staff documented calls to the pharmacy, the resident's treatment remained incomplete.
Urinary tract infections in nursing home residents require prompt, consistent antibiotic treatment. The prescribed regimen was designed with specific dosing schedules: the higher-dose Levofloxacin was meant to provide an initial therapeutic boost, followed by a lower maintenance dose every 48 hours for 10 days.
Instead, the resident's medication administration record shows gaps where critical doses should have been given. The September 13 and September 14 dates passed without the Levofloxacin 750 mg dose being administered, despite the nurse practitioner's clear orders.
Federal inspectors attempted to interview both the nurse practitioner who ordered the medications and the licensed practical nurse who documented the pharmacy calls. Both were unsuccessful in reaching the staff members.
The medication errors occurred during a complaint inspection at the facility. Inspectors reviewed antibiotic administration for four residents and found the significant errors affected one patient.
The facility policy on medication ordering states that nurses must report problems promptly. But the documentation shows a pattern of delayed communication and unresolved medication availability issues that left the resident without ordered treatment.
The missed Meropenem dose on September 14 represented a gap in the seven-day course that had started September 9. The absent Levofloxacin 750 mg dose meant the resident never received the intended initial therapeutic level of that antibiotic.
By the time staff documented that the Levofloxacin would be "delivered that night" on September 14, the resident had already missed two days of the prescribed medication. The lower-dose Levofloxacin regimen was scheduled to begin September 15, but without the higher initial dose, the treatment protocol remained incomplete.
The Director of Nursing's confirmation that no authorization requests were received from the pharmacy suggests a breakdown in communication between the facility and its medication supplier. Meanwhile, the resident continued to have a documented urinary tract infection requiring the specific antibiotic treatment that was ordered but not delivered.
Federal inspectors classified the violation as causing minimal harm or potential for actual harm. But for the resident with the UTI, the missed doses meant days without the full prescribed treatment for an infection that can lead to serious complications in elderly patients if not properly treated.
The inspection found that The Pearl of Joliet failed to ensure residents are free from significant medication errors, a basic requirement for nursing home care that protects some of the most vulnerable patients in the healthcare system.
Full Inspection Report
The details above represent a summary of key findings. View the complete inspection report for Pearl of Joliet, The from 2025-10-17 including all violations, facility responses, and corrective action plans.